70 phenotypes from 8 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
RelM1Btlr/Rel+ C57BL/6J-RelM1Btlr	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	decreased response to antigen	J:236682
	impaired hematopoiesis	J:236682
	increased CD4-positive, alpha-beta T cell number	J:236682
	increased T cell number	J:236682
RelM1Btlr/RelM1Btlr C57BL/6J-RelM1Btlr	decreased B-1 B cell number	J:236682
	decreased CD4-positive, alpha-beta T cell number	J:236682
	decreased CD8-positive, alpha-beta T cell number	J:236682
	decreased IgE level	J:236682
	decreased IgG level	J:236682
	decreased IgM level	J:236682
	decreased response to antigen	J:236682
	impaired hematopoiesis	J:236682
	increased CD4-positive, alpha-beta T cell number	J:236682
	increased CD8-positive, alpha-beta T cell number	J:236682
	increased effector memory CD4-positive, alpha-beta T cell number	J:236682
	increased T cell number	J:236682
RelM2Btlr/RelM2Btlr C57BL/6J-RelM2Btlr	abnormal CD4-positive T cell differentiation	J:272778
	abnormal T cell differentiation	J:272778
	decreased alpha-beta T cell number	J:272778
	decreased B-1 B cell number	J:272778
	decreased CD4-positive, alpha-beta T cell number	J:272778
	decreased central memory CD4-positive, alpha-beta T cell number	J:272778
	decreased effector memory CD4-positive, alpha-beta T cell number	J:272778
Relm3Btlr/Relm3Btlr C57BL/6J-Relm3Btlr	decreased IgM level	J:272801
	impaired humoral immune response	J:272801
Reltm1b(EUCOMM)Wtsi/Reltm1b(EUCOMM)Wtsi C57BL/6N-Reltm1b(EUCOMM)Wtsi/H	absent vibrissae	J:211773
	decreased monocyte cell number	J:211773
	impaired glucose tolerance	J:211773
	tremors	J:211773
Reltm1Brv/Reltm1Brv involves: 129S1/Sv	abnormal leukocyte physiology	J:46911
	abnormal liver morphology	J:46911
	abnormal lung morphology	J:46911
	abnormal macrophage morphology	J:46911
	abnormal macrophage physiology	J:46911
	abnormal skeleton morphology	J:46911
	abnormal spleen morphology	J:46911
	abnormal splenic cell ratio	J:46911
	abnormal stomach morphology	J:46911
	abnormal T cell physiology	J:46911
	decreased bone marrow cell number	J:46911
	decreased IgG1 level	J:46911
	decreased IgG2b level	J:46911
	decreased IgG3 level	J:46911
	decreased IgG level	J:46911
	decreased spleen germinal center number	J:46911
	dermatitis	J:46911
	enlarged lymph nodes	J:46911
	enlarged spleen	J:46911
	extramedullary hematopoiesis	J:46911
	impaired macrophage chemotaxis	J:46911
	increased IgA level	J:46911
	increased IgG2a level	J:46911
	increased IgM level	J:46911
	increased spleen B cell follicle size	J:46911
	increased susceptibility to bacterial infection	J:46911
	premature death	J:46911
Reltm1Grd/Rel+ involves: 129S1/Sv * C57BL/6	abnormal humoral immune response	J:28435
	decreased B cell proliferation	J:28435
Reltm1Grd/Reltm1Grd involves: 129S1/Sv	normal immune system phenotype	J:113514
Reltm1Grd/Reltm1Grd involves: 129S1/Sv * C57BL/6	abnormal cytokine secretion	J:28435, J:37541
	abnormal humoral immune response	J:28435
	abnormal macrophage physiology	J:37541
	decreased B cell proliferation	J:28435
	decreased IgG1 level	J:28435
	decreased IgG2a level	J:28435
	decreased IgG2b level	J:28435
	decreased IgG3 level	J:28435
	decreased IgM level	J:28435
	decreased susceptibility to parasitic infection	J:37541
	decreased T cell proliferation	J:28435
Reltm1Hcl/Rel+ involves: 129S4/SvJae * C57BL/6	decreased T cell proliferation	J:53513
Reltm1Hcl/Reltm1Hcl involves: 129S4/SvJae * C57BL/6	abnormal CD4-positive, alpha-beta T cell physiology	J:79107, J:118907
	abnormal cell cycle	J:75621
	abnormal cytokine secretion	J:53513, J:79107
	abnormal dendritic cell physiology	J:118907
	abnormal macrophage physiology	J:118907
	abnormal memory B cell number	J:75621
	abnormal professional antigen presenting cell physiology	J:118907
	abnormal T-helper 1 cell differentiation	J:79107
	decreased apoptosis	J:118907
	decreased B cell proliferation	J:75621
	decreased cytotoxic T cell cytolysis	J:53513
	decreased DNA replication	J:75621
	decreased IgE level	J:58987
	decreased susceptibility to autoimmune diabetes	J:118907
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:79107
	decreased T cell proliferation	J:53513, J:79107
	normal immune system phenotype	J:53513, J:58987, J:118907
	increased eosinophil cell number	J:58987
	increased neuron apoptosis	J:111862
	normal respiratory system phenotype	J:58987
Reltm1Ukl/Reltm1Ukl B6.129S1-Reltm1Ukl/J	no abnormal phenotype detected	J:101977